Injective Protocol (INJ) rose 7.60% over the past 24 hours to reach $7.67 on November 4, 2026, marking a notable single-session advance for the cryptocurrency. The token's market capitalization stood at $0.71 billion following the move.
Despite the daily gain, INJ's broader trend remains mixed. The token is down 3.50% over the past seven days, indicating that Tuesday's advance has only partially offset recent losses.
Over a longer horizon, the picture improves modestly. INJ has gained 1.59% over the past 30 days, suggesting the asset has held a slight positive bias over the past month even as shorter-term volatility has weighed on its price.
The combination of a strong daily gain, a negative weekly reading, and a small monthly gain reflects the uneven trading environment that has characterized Injective Protocol's recent price action.
